Neostigmine is not able to cross blood brain barrier because of its
**Core Concept**
The question tests the understanding of the **blood-brain barrier (BBB)** and its effects on drug permeability, particularly for **neostigmine**, a **cholinesterase inhibitor**. The BBB is a highly selective permeable barrier that separates the circulating blood from the brain's extracellular fluid.
**Why the Correct Answer is Right**
Neostigmine is a **quaternary ammonium compound**, which makes it a **polar** and **charged molecule**. This characteristic prevents it from crossing the **lipid-rich** blood-brain barrier, as it is unable to diffuse through the **lipid bilayer** of the capillary endothelial cells.
**Why Each Wrong Option is Incorrect**
**Option A:** This choice is not provided, however, typically incorrect options would relate to incorrect properties of neostigmine or the BBB.
**Option B:** Similarly, without the specific option, we can infer that any option not related to the **quaternary ammonium structure** of neostigmine would be incorrect.
**Option C:** and **Option D:** would also be incorrect for the same reason, lacking relevance to the **polarity** and **charge** of neostigmine.
**Clinical Pearl / High-Yield Fact**
It's crucial to remember that **quaternary ammonium compounds**, like neostigmine, are **poorly absorbed** from the gut and do not cross the **blood-brain barrier**, limiting their effects to the **peripheral nervous system**.
**Correct Answer:** D. Quaternary ammonium structure.